<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[BAT 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=41401></link><description><![CDATA[BAT 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Mon, 04 May 2026 15:07:33 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/09/12_31017998_20220907091338_3110503134.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[BAT Announces 70% of Policy Experts Continue to Misidentify Nicotine as Primary Cause of Smoking-related Disease]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1020237</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--BAT announces that a new multi-market survey of policy experts across 15 different territories reveals that erroneous perceptions of nicotine health risks continue to persist, despite both the growing scientific consensus that nicotine is not a primary cause of smoking-related disease and the increased availability of smokeless alternatives to c...]]></description><pubDate>Thu, 09 Oct 2025 11:20:00 +0900</pubDate></item><item><title><![CDATA[BAT, 정책 전문가 70%가 니코틴을 흡연 관련 질병의 1차 원인으로 오인하고 있다고 밝혀]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1020240</link><description><![CDATA[런던, 영국--(Business Wire/뉴스와이어)--브리티시 아메리칸 타바코(British American Tobacco, 이하 BAT)가 15개 지역 정책 전문가 대상의 새로운 다국가 설문조사 결과를 발표했다. 결과에 따르면 니코틴이 흡연 관련 질병의 주원인이 아니라는 과학적 합의가 커지고 있다. 하지만 기존 담배에 대한 무연 대체 제품의 이용 가능성이 증가했음에도 불구하고, 니코틴 건강 위험에 대한 잘못된 인식이 여전히 지속되...]]></description><pubDate>Thu, 09 Oct 2025 11:20:00 +0900</pubDate></item><item><title><![CDATA[BAT Outlines Five-Step Plan Towards Better Regulation of Vapour Sector]]></title><link>https://www.newswire.co.kr/newsRead.php?no=974877</link><description><![CDATA[SEOUL, Republic of Korea--(Business Wire/Korea Newswire)--A blueprint for how regulators and governments could better regulate vapour products and help smokers switch to less risky*† products has been outlined today by Kingsley Wheaton, BAT’s Chief Strategy &amp; Growth Officer as the Global Tobacco &amp; Nicotine Forum (GTNF) opened in South Korea.  Mr Wheaton explained how BAT’s five-step plan for re...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2023/09/31017998_20230920171143_6295084548.jpg]]></url></image><pubDate>Wed, 20 Sep 2023 17:27:36 +0900</pubDate></item><item><title><![CDATA[New Clinical Data on Vuse Illustrates Beneficial Public Health Impact of Tobacco Harm Reduction]]></title><link>https://www.newswire.co.kr/newsRead.php?no=967881</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--New results from one of the largest ever vapour product studies, which analysed BAT’s flagship vapour brand Vuse, have been published in the journal of Internal and Emergency Medicine .  The study compared clinical measurements from exclusive Vuse consumers with smokers. The results of the study show that participating Vuse consumers had favoura...]]></description><pubDate>Wed, 31 May 2023 17:30:00 +0900</pubDate></item><item><title><![CDATA[뷰즈에 대한 새로운 임상 데이터, 담배 유해성 감소가 공중 보건에 미치는 유익한 영향 설명]]></title><link>https://www.newswire.co.kr/newsRead.php?no=967882</link><description><![CDATA[런던--(Business Wire/뉴스와이어)--BAT의 대표 전자담배 브랜드인 뷰즈(Vuse)를 분석한 사상 최대 규모의 전자담배 제품 연구의 새로운 결과가 국제 학술지인 내과·응급의학과(Internal and Emergency Medicine)에 게재됐다.  이번 연구는 뷰즈만 사용한 소비자와 일반 흡연자의 임상 측정을 비교했다. 연구 결과에 따르면 뷰즈 소비자는 흡연자와 비교했을 때 흡연 관련 질병과 관련된 노출 생체지표(biomark...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2023/05/1028147215_20230531164638_7504905785.jpg]]></url></image><pubDate>Wed, 31 May 2023 17:30:00 +0900</pubDate></item><item><title><![CDATA[Reduced-risk[*] Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study]]></title><link>https://www.newswire.co.kr/newsRead.php?no=957897</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--New results from an innovative cross-sectional clinical study of Velo [i], BAT’s flagship modern oral nicotine pouch product, have been published today in Biomarkers Journal. In the study, consumers exclusively using Velo for over six months had significant favourable differences in several biomarkers of exposure and biomarkers of potential harm...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2022/12/31017998_20221214135434_1151150028.jpg]]></url></image><pubDate>Wed, 14 Dec 2022 14:20:00 +0900</pubDate></item><item><title><![CDATA[New study reveals positive long-term impact of switching from cigarettes to glo™]]></title><link>https://www.newswire.co.kr/newsRead.php?no=950838</link><description><![CDATA[LONDON--(Business Wire/Korea Newswire)--The full results from a year-long study showed that smokers switching exclusively to glo, BAT’s flagship Tobacco Heating Product (THP), achieved significant and sustained improvements in several indicators of potential harm associated with early disease development compared to smokers who continued to smoke. This included lung disease, cancer, a...]]></description><pubDate>Wed, 07 Sep 2022 10:10:00 +0900</pubDate></item><item><title><![CDATA[BAT, ‘일반 담배에서 글로로 전환 시 흡연자에게 긍정적이고 장기적인 영향 미쳐’ 연구 결과 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=950839</link><description><![CDATA[런던--(Business Wire/뉴스와이어)--1년간 진행한 연구 결과에 따르면 BAT를 대표하는 가열 담배(Tobacco Heating Product, THP) ‘글로(glo)’로 전환한 흡연자들이 일반 담배를 계속 피운 흡연자들보다 폐 질환, 암, 심혈관질환(CVD) 등의 초기 질병 진행과 관련된 여러 잠재적 위해 지표가 지속해서 크게 개선된 것으로 나타났다.   국제 학술지 체내응급의학(Internal and Emergency Medicine)[1]에 게재된 ...]]></description><pubDate>Wed, 07 Sep 2022 10:10:00 +0900</pubDate></item></channel></rss>